Vir Biotechnology, Inc.
VIRNasdaqCIK 1706431HealthcareFiscal year ends Dec 31
Reports and events: 152 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2808:37 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-067742 |
| 2026-10-1408:35 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-065826 |
| 2026-10-0808:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-065408 |
| 2026-10-0108:34 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-064117 |
| 2026-08-0517:20 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-053549 |
| 2026-08-0516:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053351 |
| 2026-07-2408:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-049499 |
| 2026-06-1016:27 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-042237 |
| 2026-05-2809:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001628280-26-038630 |
| 2026-05-0717:32 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-031471 |
| 2026-05-0616:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-031273 |
| 2026-04-1608:46 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001628280-26-025379 |
| 2026-04-1016:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-151209 |
| 2026-03-0416:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-091447 |
| 2026-03-0317:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001012975-26-000222 |
| 2026-03-0209:01 ET | 8-K | 8.01 Other events | 0001193125-26-084367 |
| 2026-02-2617:20 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-077416 |
| 2026-02-2317:27 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-010749 |
| 2026-02-2317:16 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-010740 |
| 2026-01-1208:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-001768 |
| 2025-12-1616:25 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-057394 |
| 2025-11-0517:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-049694 |
| 2025-11-0516:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-049561 |
| 2025-08-0617:31 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-038431 |
| 2025-08-0616:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-038329 |
| 2025-07-2409:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-035847 |
| 2025-05-2916:21 ET | 8-K | 5.07 Shareholder vote results | 0001628280-25-028356 |
| 2025-05-0908:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-024067 |
| 2025-05-0817:33 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-023291 |
| 2025-05-0716:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-023175 |
| 2025-04-1708:33 ET | DEF 14A | Proxy statementPeriod 2025-05-29 | 0001628280-25-018119 |
| 2025-02-2717:34 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-008245 |
| 2025-02-2616:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-008163 |
| 2025-01-3007:51 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-25-003073 |
| 2025-01-0807:50 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-003214 |
| 2024-11-0416:09 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-044995 |
| 2024-10-3116:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-044563 |
| 2024-09-1008:10 ET | 8-K | 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-039948 |
| 2024-08-0116:43 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-034195 |
| 2024-08-0116:10 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001628280-24-034143 |
| 2024-08-0116:08 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-24-191500 |
| 2024-06-2608:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-168554 |
| 2024-06-0506:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-154636 |
| 2024-05-2916:06 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-149139 |
| 2024-05-0316:16 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-020299 |
| 2024-05-0216:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-020009 |
| 2024-04-1908:32 ET | DEF 14A | Proxy statementPeriod 2024-05-29 | 0001140361-24-020684 |
| 2024-04-1808:44 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-100072 |
| 2024-02-2616:10 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-006852 |
| 2024-02-2216:12 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-006346 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 08:38 ET. Listed shows no prices and gives no investment advice.